Defence Therapeutics Inc (QB) (DTCFF)
USOTC
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -179k | -974k | -2.97M | -2.37M | -12.82M |
| Pre Tax Income | -673k | -2.86M | -7.34M | -6.87M | -13.19M |
| Net Income | -673k | -2.86M | -7.34M | -6.76M | -13.19M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.036 | -0.081 | -0.2 | -0.154 | -0.29 |
| EBIT | -179k | -974k | -2.97M | -2.37M | -12.82M |
| EBITDA | -179k | -974k | -2.97M | -2.36M | -12.73M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
